摘要
卵巢癌是女性生殖系统中常见的恶性肿瘤,死亡率占首位。临床观察发现,卵巢癌合并糖尿病者并不少,血糖异常的卵巢癌患者分期晚、容易复发和转移,预后较差。18F-FDG PET/CT显像可从分子水平无创探测恶性肿瘤功能及代谢的改变,在卵巢癌的诊断、分期、评估疗效和预后等方面起重要作用。本文对不同血糖浓度卵巢癌患者与18F-FDG PET/CT显像之间关系进行综述。
Ovarian cancer is a common malignant tumor in the female reproductive system,with mortality accounting for the first place.Clinical observation found that ovarian cancer with diabetes is not uncommon.Ovarian cancer patients with abnormal blood glucose have the characteristics of late stage,easy recurrence and metastasis,and poor prognosis.18F-FDG PET/CT imaging can noninvasively detect the functional and metabolic changes of malignant tumors at the molecular level,so it plays an important role in the diagnosis,staging,evaluation of efficacy and prognosis of ovarian cancer.This article reviews the relationship between ovarian cancer patients with different blood glucose levels and 18F-FDG PET/CT imaging.
作者
西尔艾力·吾门尔(综述)
赵艳萍(审校)
XIERAILI Wumener;ZHAO Yan-ping(Xinjiang Medical University,Urumqi 830001,Xinjiang,CHINA;Department of Nuclear Medicine,Third School of Clinical Medicine,Xinjiang Medical University,Urumqi 830001,Xinjiang,CHINA)
出处
《海南医学》
CAS
2019年第21期2825-2827,共3页
Hainan Medical Journal
基金
新疆维吾尔自治区自然科学基金(编号:2017D01C374)
